Aspergillus spondylodiscitis in solid organ transplant recipients

Area of Science:

• Medical Mycology
• Infectious Diseases
• Transplantation Medicine

Background:

• Transplantation significantly impacts invasive Aspergillosis epidemiology.
• Aspergillus spondylodiscitis is an uncommon complication in transplant recipients.
• Optimal management strategies for this rare condition require further definition.

Purpose of the Study:

• To review the literature on Aspergillus spondylodiscitis in solid organ transplant recipients.
• To provide evidence-based recommendations for managing this rare fungal infection.

Main Methods:

• Literature review of 15 identified cases of Aspergillus spondylodiscitis in transplant recipients.
• Analysis of patient demographics, clinical presentation, affected spinal location, and causative Aspergillus species.
• Evaluation of treatment modalities and patient outcomes.

Main Results:

• Most cases occurred in heart transplant recipients, with back pain as the primary symptom and lumbar spine as the most frequent site.
• Aspergillus fumigatus was the predominant species (84.62%).
• An overall recovery rate of 66.67% was observed, with delayed diagnosis hindering treatment success. Combined antifungal therapy and surgery, particularly with voriconazole, showed better results.

Conclusions:

• Combined medical and operative interventions are recommended for treating Aspergillus spondylodiscitis in transplant recipients.
• Early diagnosis and prompt, aggressive treatment are crucial for improving patient outcomes.